Skip to main content
Newron Pharmaceuticals S.p.A. logo

Newron Pharmaceuticals S.p.A. — Investor Relations & Filings

Ticker · NWRN ISIN · IT0004147952 LEI · 8156002F8C11F80A9740 SW Manufacturing
Open in API
Filings indexed 135 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country IT Italy
Listing SW NWRN

About Newron Pharmaceuticals S.p.A.

https://www.newron.com/

Newron Pharmaceuticals is a biopharmaceutical company focused on the research and development of novel therapies for diseases of the central and peripheral nervous system (CNS) and pain. The company's portfolio includes Xadago® (safinamide), a globally partnered treatment for Parkinson's disease. Its clinical-stage pipeline is centered on CNS disorders, with a key candidate, evenamide, under investigation for the treatment of schizophrenia.

Recent filings

Filing Released Lang Actions
Newron gibt eine Aussetzung der Rekrutierung neuer Studienteilnehmer in US-Zentren der ENIGMA-TRS 2-Studie bekannt
Regulatory Filings Classification · 1% confidence The document is an ad‐hoc inside information announcement under EU Market Abuse Regulation (MAR) notifying the market of an FDA hold on patient recruitment in a clinical study. It does not present financial results, management changes, share transactions, dividends, or other specific report content. It is a regulatory‐mandated news release and falls into the fallback category of general regulatory filings. Therefore, the appropriate classification is RNS.
2026-04-29 German
EQS-Adhoc: Newron gibt eine Aussetzung der Rekrutierung neuer Studienteilnehmer in US-Zentren der ENIGMA-TRS 2-Studie bekannt
Regulatory Filings Classification · 1% confidence The document is an ad hoc announcement under Article 53 of the Swiss Code of Obligations/Market Abuse Regulation (EU 596/2014), disclosing insider information about a clinical trial hold by the FDA. It is not an earnings release, financial report, or management discussion, but a mandatory regulatory news disclosure. This falls under general regulatory filings.
2026-04-29 German
Newron announces AGM 2026 results
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a corporate news announcement reporting the results of motions voted on at the Annual General Meeting (AGM), including election of board members and quorum details. This corresponds to a Declaration of Voting Results and Voting Rights announcement rather than the AGM materials themselves.
2026-04-23 English
EQS-News: Newron announces AGM 2026 results
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a news release announcing the outcome of votes at the 2026 Annual General Meeting, including approval of motions and election of board members. This matches the definition for Declaration of Voting Results & Voting Rights Announcements.
2026-04-23 English
EQS-News: Newron vermeldet die Resultate der Generalversammlung 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a corporate news release reporting the vote outcomes of the Annual General Meeting (Generalversammlung), listing approved agenda items and newly elected board members. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-04-23 German
Newron gibt Geschaftsergebnisse 2025 und Ausblick 2026 bekannt
Earnings Release Classification · 1% confidence The document is an ad-hoc press release under Article 17 of EU Reg 596/2014 announcing Newron’s full‐year 2025 financial and operational highlights and providing an outlook for 2026, with key metrics, net profit/loss figures, and arrangements for an earnings teleconference. It does not include full financial statements or MD&A but rather the initial, summarized announcement of year-end results. This aligns with an Earnings Release (ER). FY 2025
2026-03-24 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.